Patent Pressures Mounting for Flu Drug Manufacturers

Drug Industry Daily
KEYWORDS International
A A

Antiviral manufacturers such as Roche and GlaxoSmithKline (GSK) are under increasing pressure to allow generic production of their vaccines, which could be effective against an avian flu outbreak, but industry opponents say opening the door for generics isn’t the solution.

To View This Article:

Login

Subscribe To Drug Industry Daily